Serial #50007742
LIVE

Serial Number

50007742

Owner

Peptilogics INC.

Attorney

Elizabeth Lee D'Amore

First Use Date

Jan 6, 2015

Filing Date

Jul 22, 2026

Add to watchlist:

No watchlists yet
View on USPTO

Serial #50007742 Trademark

Serial Number: 50007742

Serial #50007742 is a trademark filed by Peptilogics INC. on July 22, 2026. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Peptilogics INC. (2 trademarks)

2681 Sidney Street
Pittsburgh, PA 15203

Entity Type: 03

Trademark Details

Filing Date

July 22, 2026

Registration Date

Not Registered

First Use Anywhere

January 6, 2015

First Use in Commerce

January 6, 2015

Goods & Services

Medical consultancy services relating to drug safety assessment; provision of information relating to the properties of pharmaceutical compounds; consultancy services relating to non-animal-based drug safety testing for regulatory purposes; medical research services in the field of pharmacology and toxicology; medical research services in the field of infectious diseases, antimicrobial therapeutics, and orthopedic infections

Scientific research and development in the field of antimicrobial peptides; research and development of pharmaceutical preparations for the prevention and treatment of infections; research and development relating to peptide discovery, peptide synthesis, and peptide characterization; research and development of anti-infective and anti-biofilm agents; drug discovery services; biotechnology research; biomedical research services; providing temporary use of non-downloadable software for use in artificial intelligence-driven drug discovery, peptide engineering, molecular modeling, pharmaceutical research, therapeutic design, bioinformatics analysis, and computational biology; providing scientific information, analysis, and consulting in the fields of bioinformatics, cheminformatics, computational biology, and peptide therapeutics; Research and development of artificial intelligence and machine learning models for predicting the properties of pharmaceutical compounds; development of in silico platforms for drug safety testing; computational modelling services in the field of pharmacology and toxicology; contract research services in the field of computational drug safety assessment

Filing History

APPLICATION FILING RECEIPT MAILED
Jul 22, 2026 MAFR
NEW APPLICATION ENTERED
Jul 22, 2026 NWAP